Mortality in Patients With Primary Aldosteronism: A Swedish Nationwide Study.

Eleftheria Gkaniatsa Tatiana Zverkova Sandström Annika Rosengren Penelope Trimpou Daniel S OlssonMarcus LindAndreas Muth Gudmundur Johannsson Oskar Ragnarsson

Published in: Hypertension (Dallas, Tex. : 1979) (2023)

Mortality, mainly due to cardiovascular disease, is increased in patients with PA compared with controls from the general population, particularly in patients aged >56 years, patients with preexisting cardiovascular comorbidities, and patients receiving low dose of a mineralocorticoid receptor antagonist.

Keyphrases

low dose
cardiovascular disease
end stage renal disease
cardiovascular events
ejection fraction
chronic kidney disease
risk factors
peritoneal dialysis
type diabetes
prognostic factors
high dose
metabolic syndrome
patient reported outcomes
cardiovascular risk factors